Singapore markets close in 2 hours 19 minutes
Straits Times Index
3,279.99 -13.14 (-0.40%) Nikkei
37,628.48 -831.60 (-2.16%) Hang Seng
17,227.54 +26.27 (+0.15%) FTSE 100
8,040.38 -4.43 (-0.06%) Bitcoin USD
64,258.98 -2,476.75 (-3.71%) CMC Crypto 200
1,390.85 +8.28 (+0.60%)
IGM Biosciences, Inc. (IGMS)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 467.94M |
| Enterprise value | 170.77M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 195.49 |
| Price/book (mrq) | 2.30 |
| Enterprise value/revenue | 80.17 |
| Enterprise value/EBITDA | -0.67 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.25 |
| 52-week change 3 | -26.30% |
| S&P500 52-week change 3 | 22.64% |
| 52-week high 3 | 17.70 |
| 52-week low 3 | 3.81 |
| 50-day moving average 3 | 10.74 |
| 200-day moving average 3 | 8.56 |
Share statistics
| Avg vol (3-month) 3 | 271.33k |
| Avg vol (10-day) 3 | 314.4k |
| Shares outstanding 5 | 33.29M |
| Implied shares outstanding 6 | 58.79M |
| Float 8 | 11.85M |
| % held by insiders 1 | 35.23% |
| % held by institutions 1 | 68.12% |
| Shares short (15 Apr 2024) 4 | 5.25M |
| Short ratio (15 Apr 2024) 4 | 23.48 |
| Short % of float (15 Apr 2024) 4 | 33.68% |
| Short % of shares outstanding (15 Apr 2024) 4 | 8.92% |
| Shares short (prior month 15 Mar 2024) 4 | 4.76M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -9,722.43% |
Management effectiveness
| Return on assets (ttm) | -34.91% |
| Return on equity (ttm) | -100.48% |
Income statement
| Revenue (ttm) | 2.13M |
| Revenue per share (ttm) | 0.04 |
| Quarterly revenue growth (yoy) | 75.00% |
| Gross profit (ttm) | N/A |
| EBITDA | -253.36M |
| Net income avi to common (ttm) | -246.42M |
| Diluted EPS (ttm) | -4.71 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 337.68M |
| Total cash per share (mrq) | 5.74 |
| Total debt (mrq) | 40.51M |
| Total debt/equity (mrq) | 19.93% |
| Current ratio (mrq) | 8.18 |
| Book value per share (mrq) | 3.46 |
Cash flow statement
| Operating cash flow (ttm) | -192.23M |
| Levered free cash flow (ttm) | -121.96M |
© 2024 Yahoo. All rights reserved.